---
schema_version: "secwatch.filing_event.v1"
accession: "0001708599-24-000029"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2024-12-18T23:59:59+00:00"
generated_at: "2026-05-29T02:02:16.316357+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Serina shareholders approve equity plan amendment increasing share reserve by 950,000 shares

## Summary
- Shareholders approved Amendment to 2024 Equity Incentive Plan, increasing shares reserved by 950,000 to 2,675,000.
- Amendment also provides for automatic annual share increase of 5% of outstanding shares from FY2026 through FY2034.
- Directors elected: Balkrishan 'Simba' Gill (5,998,349 votes), Remy Gross (5,963,359), Steven Mintz (5,953,931).
- Ratification of Frazier & Deeter as independent auditors approved with 7,162,782 votes for, 90,321 against.

## SEC filing metadata
- accession: 0001708599-24-000029
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2024-12-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000170859924000029/0001708599-24-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000170859924000029/ser-20241213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001708599-24-000029
- JSON: https://secwatch.observer/filing/0001708599-24-000029.json
- Plain text: https://secwatch.observer/filing/0001708599-24-000029.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.